Efficacy and safety of Tengfu Jiangya tablet combined with valsartan/amlodipine in the treatment of stage 2 hypertension: study protocol for a randomized controlled trial

BACKGROUND: The prevalence rate of hypertension in the Chinese population is on the rise, and the control rate of hypertension is low. International guidelines, including the 2018 Chinese Guidelines for the Management of Hypertension, recommend optimized drug selection and combination therapy for pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yu, Hua, Zhen, Chen, Wenjing, Zhu, Yushuo, Li, Yunlun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8864829/
https://www.ncbi.nlm.nih.gov/pubmed/35193665
http://dx.doi.org/10.1186/s13063-022-06089-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8864829/
https://www.ncbi.nlm.nih.gov/pubmed/35193665
http://dx.doi.org/10.1186/s13063-022-06089-z

Ejemplares similares